The quantitative assay of
protein S can help in rapidly identifying carriers of abnormal
protein S molecules through a simple procedure (by determining the total
protein S mass, total
protein S activity, and
protein S-specific activity in blood), without genetic testing. To clarify the relationship between
venous thromboembolism (VTE) and
protein S-specific activity, and its role in the diagnosis of
thrombosis in Japanese persons, the
protein S-specific activity was measured and compared between patients with
thrombosis and healthy individuals. The
protein S-specific activity of each participant was calculated from the ratio of total
protein S activity to total
protein S antigen level. Plasma samples were collected from 133 healthy individuals, 57 patients with
venous thrombosis, 118 patients with arterial
thrombosis, and 185 non-thrombotic patients. The
protein S-specific activity of one-third of the patients with VTE was below the line of Y = 0.85X (-2 S.D.). Most
protein S activities in the plasma of non-thrombotic patients were near the Y = X line, as observed in healthy individuals. In conclusion, it was clearly shown that monitoring
protein S activity and
protein S-specific activity in blood is useful for predicting the onset and preventing
venous thrombosis in at least the Japanese population.